The rise and fall of primary hyperparathyroidism: A population-based study in Rochester, Minnesota, 1965-1992

被引:202
作者
Wermers, RA [1 ]
Khosla, S [1 ]
Atkinson, EJ [1 ]
Hodgson, SF [1 ]
OFallon, WM [1 ]
Melton, LJ [1 ]
机构
[1] MAYO CLIN & MAYO FDN, ROCHESTER, MN 55905 USA
关键词
hyperparathyroidism; calcium; hypercalcemia; parathyroid hormones; population surveillance;
D O I
10.7326/0003-4819-126-6-199703150-00003
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: The introduction of routine measurement of serum calcium levels led to a sharp increase in the incidence of primary hyperparathyroidism in the early 1970s. Objective: To evaluate the trends in the incidence of primary hyperparathyroidism since the mid-1970s. Setting: Rochester and Olmsted County, Minnesota. Design: Population-based descriptive study. Patients: All residents of Rochester, Minnesota, who received an initial diagnosis of primary hyperparathyroidism between 1965 and 1992 were identified through the medical records linkage system of the Rochester Epidemiology Project. Included as persons having definite cases (92% of the total) were patients with pathologically confirmed hyperparathyroidism, hypercalcemia with inappropriately elevated parathyroid hormone levels, or hypercalcemia that had lasted for more than a year and had no cause other than primary hyperparathyroidism. Measurements: Incidence rates were calculated and directly standardized to the population structure of white persons in the United States in 1990. Results: From 1965 to June 1974 (the prescreening era), the age- and sex-adjusted incidence of primary hyperparathyroidism in Rochester was 15 cases per 100 000 person-years. After measurement of calcium levels was added to the automated serum chemistry panel in July 1974, the incidence increased to 112 per 100 000 person-years in 1975 and then decreased somewhat, reflecting a sweeping effect. Despite improved case ascertainment, however, the incidence rate has continued to decrease; in 1992, the incidence was 4 per 100 000 person-years. A few patients had complications that might have been caused by hyperparathyroidism (22% between 1965 and June 1974 and 6% thereafter), and survival was not impaired in either period. The maximum serum calcium levels did not change (P = 0.15). Conclusions: The progressive decrease in the incidence of primary hyperparathyroidism is unexpected and suggests a significant change in the epidemiology of this disease.
引用
收藏
页码:433 / +
页数:1
相关论文
共 68 条
[1]   EFFECT OF MULTIPHASIC BIOCHEMICAL SCREENING ON DIAGNOSIS OF PRIMARY HYPERPARATHYROIDISM [J].
AITKEN, RE ;
BARTLEY, PC ;
BRYANT, SJ ;
LLOYD, HM .
AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 1975, 5 (03) :224-226
[2]   RADIOIMMUNOASSAY OF HUMAN PARATHYROID HORMONE IN SERUM [J].
ARNAUD, CD ;
TSAO, HS ;
LITTLEDIKE, T .
JOURNAL OF CLINICAL INVESTIGATION, 1971, 50 (01) :21-+
[3]   MONOCLONALITY OF PARATHYROID TUMORS IN CHRONIC-RENAL-FAILURE AND IN PRIMARY PARATHYROID HYPERPLASIA [J].
ARNOLD, A ;
BROWN, MF ;
URENA, P ;
GAZ, RD ;
SARFATI, E ;
DRUEKE, TB .
JOURNAL OF CLINICAL INVESTIGATION, 1995, 95 (05) :2047-2053
[4]  
AVIS NE, 1990, ANN NY ACAD SCI, V592, P228
[5]   YIELD OF MULTIPHASIC SCREENING [J].
BATES, B ;
YELLIN, JA .
JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1972, 222 (01) :74-+
[6]   THERAPEUTIC RADIATION AND HYPERPARATHYROIDISM - A CASE-CONTROL STUDY IN ROCHESTER, MINN [J].
BEARD, CM ;
HEATH, H ;
OFALLON, WM ;
ANDERSON, JA ;
EARLE, JD ;
MELTON, LJ .
ARCHIVES OF INTERNAL MEDICINE, 1989, 149 (08) :1887-1890
[7]  
Bergstralh E., 1992, CALCULATING INCIDENC
[8]  
BOONSTRA CE, 1971, AM J CLIN PATHOL, V55, P523
[9]  
BULLAMORE JR, 1970, LANCET, V2, P535
[10]   HYPERPARATHYROIDISM AFTER NECK IRRADIATION [J].
CHRISTMAS, TJ ;
CHAPPLE, CR ;
NOBLE, JG ;
MILROY, EJG ;
COWIE, AGA .
BRITISH JOURNAL OF SURGERY, 1988, 75 (09) :873-874